By Kelly J. O’Brien – Technology Reporter, Boston Business Journal December 20, 2018, 4:39pm EST Beverly-based HighRes Biosolutions Inc. has named a new CEO as it aims to expand the reach of its robotic arms throughout the pharmaceutical world. Ira Hoffman, formerly the company’s president, will become CEO of February 1, replacing current CEO Peter […]
Written by: Peter Harris, CEO, HighRes Biosolutions The escalating cost of discovering new biopharmaceutical therapies is a well-known and long-standing problem. Recent estimates by the Tufts Center for the Study of Drug Development put the cost of developing and getting approval for a new drug just shy of $3 billion1. The underlying buildup of costs, […]
Lab automation has come a long way since the days of industrial robots, with new advancements increasing efficiency between systems and workers. Peter Harris, HighRes Biosolutions, discusses how far the sector has moved and what the future holds. The use of automation and robotics in scientific research has been around for quite some time, starting […]
Tonya Hall sits down with Peter Harris, CEO at HighRes Biosolutions, about how robotic systems are being used for new drug discoveries. See the full video here.
As an integrator, HighRes Biosolutions intimately knows its customers’ needs, as the biopharmaceuticals industry looks to save money and speed testing with robots.’ The pharmaceuticals industry is ideal for robotics, requiring precision, repeatability, and strict standards compliance. Scientists working on drug discovery, molecular diagnostics, and other research rely on integrators such as HighRes Biosolutions Inc. […]
Modular automation from HighRes Biosolutions lets lab technicians quickly disconnect, move, and reconnect mobile carts containing robotic arms and other devices, expanding the range of experiments that can be performed at a single site. The Benefit One HighRes system can do the work of 20 to 30 lab techs with fewer errors, enabling faster development […]
Robotic lab techs don’t need to stop for rest. Unlike humans, they can shuttle samples 24/7. Featured on WSJ.com By Daniela Hernandez The scientist hunched over beakers, conducting drug research by hand, may soon be a memory. Companies like Eli Lilly & Co. and GlaxoSmithKline PLC are investing in automation with the hope of transforming […]
From Robotics Business Review For biopharmaceutical companies looking to discover the next big breakthrough in the fight against cancer, automating their processes can literally be a matter of life and death. With billions of dollars being spent to research drug discovery, finding ways to more quickly automate research is a high priority. HighRes Biosolutions aims […]
Life Sciences Labs Need Cobots, Not Robots The John Henry legend, as told by Johnny Cash, not only recalls a competition between a steel-driving man and a steamdrill, it also suggests that the competition was poorly conceived: John Henry said to the steamdrill, “How is you? / Pardon me, Mister Steamdrill, I suppose you didn’t […]
Collaborative robots, ultrasonic acoustic energy, picodroplet technology, and cloud computing are among the technologies advancing liquid handling—simplifying workflows and raising efficiency and productivity levels. These new, often automated, and efficient solutions are frequently enabled by connections—between human operators and robots, among complementary technologies, or via the cloud. Working with robots Massachusetts-based HighRes Biosolutions develops robotic […]